Pharmaceutics (Sep 2022)

Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells

  • Ala Amgheib,
  • Ruisi Fu,
  • Eric O. Aboagye

DOI
https://doi.org/10.3390/pharmaceutics14102040
Journal volume & issue
Vol. 14, no. 10
p. 2040

Abstract

Read online

Non-invasive positron emission tomography (PET) imaging of immune cells is a powerful approach for monitoring the dynamics of immune cells in response to immunotherapy. Despite the clinical success of many immunotherapeutic agents, their clinical efficacy is limited to a subgroup of patients. Conventional imaging, as well as analysis of tissue biopsies and blood samples do not reflect the complex interaction between tumour and immune cells. Consequently, PET probes are being developed to capture the dynamics of such interactions, which may improve patient stratification and treatment evaluation. The clinical efficacy of cancer immunotherapy relies on both the infiltration and function of cytotoxic immune cells at the tumour site. Thus, various immune biomarkers have been investigated as potential targets for PET imaging of immune response. Herein, we provide an overview of the most recent developments in PET imaging of immune response, including the radiosynthesis approaches employed in their development.

Keywords